{"id":"https://openalex.org/W2047553605","doi":"https://doi.org/10.3810/pgm.2014.05.2753","title":"Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results","display_name":"Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W2047553605","doi":"https://doi.org/10.3810/pgm.2014.05.2753","mag":"2047553605","pmid":"https://pubmed.ncbi.nlm.nih.gov/24918789"},"language":"en","primary_location":{"id":"doi:10.3810/pgm.2014.05.2753","doi":"https://doi.org/10.3810/pgm.2014.05.2753","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2014.05.2753","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2047553605"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061317385","display_name":"Keith Usiskin","orcid":"https://orcid.org/0000-0003-4806-6554","observed_orcids":["https://orcid.org/0000-0003-4806-6554"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keith Usiskin","raw_affiliation_strings":["Senior Director and Clinical Leader, Janssen Research & Development, LLC, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Senior Director and Clinical Leader, Janssen Research & Development, LLC, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069057602","display_name":"Irina Kline","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Irina Kline","raw_affiliation_strings":["Director of Metabolism, Janssen Research & Development, LLC, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of Metabolism, Janssen Research & Development, LLC, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011599056","display_name":"Albert Fung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Albert Fung","raw_affiliation_strings":["Associate Director and Clinical Project Scientist, Janssen Research & Development, LLC, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Associate Director and Clinical Project Scientist, Janssen Research & Development, LLC, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077346926","display_name":"Cristiana Mayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cristiana Mayer","raw_affiliation_strings":["Scientific Director, Statistical Modeling MBDD, Janssen Research & Development, LLC, Titusville, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scientific Director, Statistical Modeling MBDD, Janssen Research & Development, LLC, Titusville, NJ","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110257714","display_name":"Gary E. Meininger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gary Meininger","raw_affiliation_strings":["Vice President, Franchise Medical Leader\u2013Metabolism, Janssen Research & Development, LLC, Raritan, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vice President, Franchise Medical Leader\u2013Metabolism, Janssen Research & Development, LLC, Raritan, NJ","institution_ids":["https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5069057602"],"corresponding_institution_ids":["https://openalex.org/I4405282460"],"apc_list":null,"apc_paid":null,"fwci":11.9416,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.99176749,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"126","issue":"3","first_page":"16","last_page":"34"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9330000281333923},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9399999976158142},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8460000157356262},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9409999847412109},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8809999823570251},{"id":"https://openalex.org/keywords/genital-mycotic-infections","display_name":"genital mycotic infections","score":0.9409999847412109},{"id":"https://openalex.org/keywords/osmotic-diuresis","display_name":"osmotic diuresis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.8320000171661377},{"id":"https://openalex.org/keywords/renal-safety","display_name":"renal safety","score":0.7360000014305115},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9739999771118164},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8949999809265137},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.7559999823570251},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.7639999985694885},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9769999980926514},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9839364290237427},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9795133471488953},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.888283371925354},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.695432186126709},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5562753081321716},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5281950235366821},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.45886489748954773},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3001418709754944},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.29545897245407104}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007677","descriptor_name":"Kidney Function Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3810/pgm.2014.05.2753","doi":"https://doi.org/10.3810/pgm.2014.05.2753","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2014.05.2753","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},{"id":"pmid:24918789","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24918789","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W175419662","https://openalex.org/W1967064223","https://openalex.org/W1982905493","https://openalex.org/W2022096337","https://openalex.org/W2031333151","https://openalex.org/W2038270027","https://openalex.org/W2038961968","https://openalex.org/W2040643300","https://openalex.org/W2068171948","https://openalex.org/W2074989651","https://openalex.org/W2077038286","https://openalex.org/W2084511068","https://openalex.org/W2090088543","https://openalex.org/W2114250030","https://openalex.org/W2120919346","https://openalex.org/W2130570549","https://openalex.org/W2135097670","https://openalex.org/W2147650224","https://openalex.org/W2150849997","https://openalex.org/W2153839551","https://openalex.org/W2162427196","https://openalex.org/W2165956693","https://openalex.org/W2167984652","https://openalex.org/W2168926920","https://openalex.org/W2171049608","https://openalex.org/W2171471305","https://openalex.org/W2172193326","https://openalex.org/W2510708214"],"related_works":["https://openalex.org/W6939906290","https://openalex.org/W2559726090","https://openalex.org/W1995006519","https://openalex.org/W1996837305","https://openalex.org/W2060263164","https://openalex.org/W2068171948","https://openalex.org/W1574738033","https://openalex.org/W2134414031","https://openalex.org/W2133537151","https://openalex.org/W2169592572"],"abstract_inverted_index":{"BACKGROUND:":[0],"Canagliflozin":[1,145,180,275,292],"is":[2],"a":[3,46],"sodium":[4],"glucose":[5],"cotransporter":[6],"2":[7,13],"inhibitor":[8],"developed":[9],"for":[10,95],"treating":[11],"type":[12],"diabetes":[14,80,312],"mellitus":[15,81,313],"(T2DM).":[16],"METHODS:":[17],"The":[18,116],"safety/tolerability":[19],"profile":[20],"of":[21,36,49,100,119,132,153,200,212,227],"canagliflozin":[22,124,218,249],"100":[23,125],"and":[24,98,103,126,129,135,157,175,261,295],"300":[25,127],"mg":[26,128],"over":[27,195],"26":[28],"weeks":[29],"was":[30,121,146,181,236,276,299],"assessed":[31],"using":[32],"an":[33],"integrated":[34],"analysis":[35],"data":[37,92],"pooled":[38],"from":[39],"4":[40],"placebo-controlled,":[41],"phase":[42],"3":[43],"studies":[44],"representing":[45],"broad":[47],"range":[48],"patients":[50,222,240,304],"with":[51,90,123,148,183,217,248,265,278,305],"T2DM":[52,306],"(N":[53],"=":[54],"2313;":[55],"mean":[56],"age,":[57],"56.0":[58],"years;":[59],"glycated":[60],"hemoglobin":[61],"[HbA1c],":[62],"8.0%;":[63],"body":[64],"mass":[65],"index,":[66],"32.1":[67],"kg/m2;":[68],"estimated":[69,187],"glomerular":[70,188],"filtration":[71,189],"rate,":[72],"88.1":[73],"mL/min/1.73":[74],"m2)":[75],"on":[76,223,242,309],"various":[77],"prespecified":[78,94],"background":[79,224,243],"treatments.":[82],"Safety/tolerability":[83],"evaluations":[84],"included":[85],"adverse":[86],"event":[87],"(AE)":[88],"reporting,":[89],"additional":[91],"collection":[93],"selected":[96],"AEs,":[97],"assessments":[99],"renal-related,":[101],"lipid,":[102],"other":[104,282],"safety":[105,283],"laboratory":[106,284],"parameters.":[107],"TRIAL":[108],"REGISTRATION:":[109],"ClinicalTrials.gov,":[110],"NCT01081834;":[111],"NCT01106625;":[112],"NCT01106677;":[113],"NCT01106690.":[114],"RESULTS:":[115],"overall":[117,238],"incidence":[118,211,235],"AEs":[120,134,136,202],"similar":[122],"placebo;":[130],"incidences":[131,150,199,226],"serious":[133],"leading":[137],"to":[138,168,171,178,253],"study":[139],"discontinuation":[140],"were":[141,162,203,215,230,263,272,287],"low":[142,204,231,237],"across":[143,205,232],"groups.":[144,206,233],"associated":[147,182,277],"higher":[149,247],"than":[151],"placebo":[152,220],"genital":[154],"mycotic":[155],"infections":[156],"osmotic":[158],"diuresis-related":[159],"AEs;":[160],"these":[161],"generally":[163,300],"considered":[164],"by":[165],"the":[166,196,210],"investigator":[167],"be":[169],"mild":[170],"moderate":[172],"in":[173,186,209,221,239,257,268,281,303],"intensity":[174],"infrequently":[176],"led":[177],"discontinuation.":[179],"transient":[184],"reductions":[185],"rate":[190],"that":[191,286],"trended":[192],"toward":[193],"baseline":[194],"assessment":[197],"period;":[198],"renal-related":[201],"Dose-related":[207],"increases":[208,267],"hypoglycemia":[213,229],"episodes":[214],"seen":[216,264],"versus":[219,250],"sulfonylurea;":[225],"severe":[228],"Hypoglycemia":[234],"not":[241,288],"sulfonylurea,":[244],"but":[245],"slightly":[246],"placebo.":[251],"Relative":[252],"placebo,":[254],"favorable":[255],"changes":[256,280],"high-density":[258],"lipoprotein":[259,270],"cholesterol":[260,271],"triglycerides":[262],"canagliflozin;":[266],"low-density":[269],"also":[273],"seen.":[274],"small":[279],"parameters":[285],"clinically":[289],"meaningful.":[290],"CONCLUSIONS:":[291],"as":[293,296],"monotherapy":[294],"combination":[297],"therapy":[298],"well":[301],"tolerated":[302],"inadequately":[307],"controlled":[308],"their":[310],"current":[311],"treatment.":[314]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2047553605","counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":23},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
